Trial Profile
Phase I trial of BBI 608 in patients with solid tumours in Japan
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 01 Aug 2013
Price :
$35
*
At a glance
- Drugs Napabucasin (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- 01 Aug 2013 New trial record
- 31 Jul 2013 This trial was initiated in the first quarter of 2013, according to a Dainippon Sumitomo Pharma report.